Edwards Lifesciences Corporation (EW) Ownership

$77.06

north_east
$0.41 (0.54%)
Day's range
$76.5
Day's range
$77.97

Edwards Lifesciences Corporation Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 11/07/2025 70.36 M $5.47 B   0.52% 11.99%
BLACKROCK, INC. 11/12/2025 54.29 M $4.22 B   -2.43% 9.25%
STATE STREET CORP 11/14/2025 25.62 M $1.99 B   -0.06% 4.36%
JPMORGAN CHASE & CO 11/26/2025 25.06 M $1.95 B   -6.41% 4.27%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 20.80 M $1.62 B   4.93% 3.54%
BANK OF NEW YORK MELLON CORP 11/03/2025 19.01 M $1.48 B   8.09% 3.24%
FMR LLC 11/13/2025 14.58 M $1.13 B   476.71% 2.48%
JENNISON ASSOCIATES LLC 10/30/2025 13.96 M $1.09 B   19.60% 2.38%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 12.84 M $993.49 M   0.90% 2.19%
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN 11/14/2025 9.24 M $718.61 M   1.21% 1.57%
NINETY ONE UK LTD 11/13/2025 7.91 M $615.05 M   13.96% 1.35%
BROWN ADVISORY INC 11/14/2025 7.36 M $572.22 M   0.62% 1.25%
MORGAN STANLEY 11/14/2025 6.51 M $506.23 M   -13.15% 1.11%
DEUTSCHE BANK AG\ 11/13/2025 6.16 M $479.35 M   2.49% 1.05%
NORTHERN TRUST CORP 11/14/2025 6.04 M $469.78 M   -1.16% 1.03%
UBS ASSET MANAGEMENT AMERICAS INC 11/14/2025 5.58 M $434.32 M   278.27% 0.95%
WELLCOME TRUST LTD (THE) AS TRUSTEE OF THE WELLCOME TRUST 11/05/2025 4.80 M $373.30 M   0.00% 0.82%
HOLOCENE ADVISORS, LP 11/14/2025 4.75 M $369.15 M   0.91% 0.81%
NUVEEN, LLC 11/12/2025 4.54 M $353.19 M   -1.41% 0.77%
NORDEA INVESTMENT MANAGEMENT AB 10/27/2025 4.25 M $328.55 M   -2.54% 0.72%
CITADEL ADVISORS LLC 11/14/2025 4.23 M $329.32 M   -66.74% 0.72%
LEGAL & GENERAL GROUP PLC 11/13/2025 4.11 M $319.38 M   -2.77% 0.70%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 3.68 M $286.47 M   9.05% 0.63%
INVESCO LTD. 11/13/2025 3.57 M $277.66 M   8.98% 0.61%
MARSHALL WACE, LLP 11/13/2025 3.57 M $277.37 M   -48.28% 0.61%
PRIMECAP MANAGEMENT CO/CA/ 11/12/2025 3.52 M $274.01 M   2.22% 0.60%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 3.45 M $268.55 M   -14.46% 0.59%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/17/2025 3.08 M $239.40 M   -10.53% 0.52%
VIKING GLOBAL INVESTORS LP 11/14/2025 3.07 M $238.69 M   100.00% 0.52%
GOLDMAN SACHS GROUP INC 11/14/2025 2.88 M $223.94 M   5.48% 0.49%
MIROVA US LLC 10/20/2025 2.82 M $219.47 M   -3.73% 0.48%
AMUNDI 11/14/2025 2.65 M $203.11 M   -23.35% 0.45%
ROYAL BANK OF CANADA 11/14/2025 2.36 M $183.79 M   -26.99% 0.40%
HSBC HOLDINGS PLC 11/13/2025 2.19 M $170.30 M   19.46% 0.37%
CHAMPLAIN INVESTMENT PARTNERS, LLC 11/12/2025 2.11 M $164.45 M   -4.91% 0.36%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 2.08 M $161.05 M   114.53% 0.35%
UBS GROUP AG 11/13/2025 2.06 M $159.89 M   11.95% 0.35%
RAYMOND JAMES FINANCIAL INC 11/14/2025 2.03 M $157.73 M   -2.53% 0.35%
MAN GROUP PLC 11/14/2025 1.97 M $153.01 M   18.95% 0.34%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2025 1.91 M $148.34 M   4.34% 0.33%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2025 1.80 M $139.99 M   100.00% 0.31%
MILLENNIUM MANAGEMENT LLC 11/14/2025 1.78 M $138.41 M   -73.37% 0.30%
BANK OF AMERICA CORP /DE/ 11/14/2025 1.77 M $137.50 M   -24.67% 0.30%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 11/07/2025 1.75 M $136.03 M   8.35% 0.30%
ALLIANZ ASSET MANAGEMENT GMBH 11/04/2025 1.75 M $136.02 M   133.16% 0.30%
DEKABANK DEUTSCHE GIROZENTRALE 11/03/2025 1.75 M $134.30 M   0.00% 0.30%
SWISS NATIONAL BANK 11/13/2025 1.69 M $131.51 M   -4.63% 0.29%
ORBIMED ADVISORS LLC 11/14/2025 1.68 M $130.96 M   -1.41% 0.29%
ASSENAGON ASSET MANAGEMENT S.A. 10/07/2025 1.64 M $127.34 M   -34.33% 0.28%
JANE STREET GROUP, LLC 11/14/2025 1.56 M $121.41 M   182.63% 0.27%

Edwards Lifesciences Corporation institutional Ownership - FAQ's

During the previous two years, 1840 institutional investors and hedge funds held shares of Edwards Lifesciences Corporation. The most heavily invested institutionals were:

VANGUARD GROUP INC: 70.36 M

BlackRock, Inc.: 54.29 M

STATE STREET CORP: 25.62 M

JPMORGAN CHASE & CO: 25.06 M

WELLINGTON MANAGEMENT GROUP LLP: 20.8 M

Bank of New York Mellon Corp: 19.01 M

83.50% of Edwards Lifesciences Corporation stock is owned by institutional investors.

Institutional investors have bought a total of 606.79 M shares in the last 24 months. This purchase volume represents approximately $46.76 B in transactions.